Top compounds associated with response to MOCS3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA CD-437 CTRPv2 pan-cancer AAC -0.069 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.079 0.04
mRNA RAF265 CTRPv2 pan-cancer AAC -0.086 0.04
mRNA foretinib CTRPv2 pan-cancer AAC -0.074 0.04
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA AZ628 GDSC1000 pan-cancer AAC 0.11 0.04
mRNA Axitinib CTRPv2 pan-cancer AAC -0.071 0.04
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.063 0.04
Download CSV